comparemela.com

Latest Breaking News On - Jean jacques bienaime - Page 7 : comparemela.com

Moody Aldrich Partners LLC Purchases 1,392 Shares of BioMarin Pharmaceutical Inc (NASDAQ:BMRN)

Moody Aldrich Partners LLC lifted its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 24.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 7,049 shares of the biotechnology company’s stock after buying an additional 1,392 shares during the period. […]

Private Ocean LLC Invests $140,000 in BioMarin Pharmaceutical Inc (NASDAQ:BMRN)

Private Ocean LLC purchased a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 1,450 shares of the biotechnology company’s stock, valued at approximately $140,000. Other institutional investors and hedge funds have […]

Private Ocean LLC Invests $140,000 in BioMarin Pharmaceutical Inc (NASDAQ:BMRN)

Private Ocean LLC Invests $140,000 in BioMarin Pharmaceutical Inc (NASDAQ:BMRN)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Receives $107 61 Average Price Target from Analysts

BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Receives $107 61 Average Price Target from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Advisors Asset Management Inc Raises Stock Position in BioMarin Pharmaceutical Inc (NASDAQ:BMRN)

Advisors Asset Management Inc. lifted its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 6.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,133 shares of the biotechnology company’s stock after buying an additional 612 shares during the quarter. […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.